Pristane induces a lupus-like syndrome in nonautoimmune mice characterized by the development of glomerulonephritis and lupus-associated autoantibodies. This is accompanied by overproduction of interleukin (IL)-6, a cytokine linked with autoimmune phenomena. The goal of this study was to evaluate the role of IL-6 in autoantibody production in pristane-induced lupus. BALB/cAn IL-6-deficient ( ϪրϪ ) and -intact ( ϩրϩ ) mice were treated with pristane or phosphate-buffered saline, and autoantibody production was evaluated. Pristane induced high levels of immunoglobulin (Ig)G anti-single-stranded DNA, -double-stranded (ds)DNA, and -chromatin antibodies in IL-6 ϩրϩ , but not IL-6 ϪրϪ mice by enzyme-linked immunosorbent assay. High titer IgG anti-dsDNA antibodies also were detected in sera from ϩրϩ , but not ϪրϪ , mice by Crithidia luciliae kinetoplast staining. The onset of IgG anti-dsDNA antibody production in ϩրϩ mice occurred Ͼ 5 mo after pristane treatment, well after the onset of nephritis, suggesting that these antibodies are not directly responsible for inducing renal disease. In contrast to anti-DNA, the frequencies of anti-nRNP/Sm and anti-Su antibodies were similar in pristane-treated IL-6 ϪրϪ and IL-6 ϩրϩ mice. However, levels were higher in the ϩրϩ group. These results suggest that IgG anti-DNA and chromatin antibodies in pristane-treated mice are strictly IL-6 dependent, whereas induction of anti-nRNP/Sm and Su autoantibodies is IL-6 independent. The IL-6 dependence of anti-DNA, but not anti-nRNP/Sm, may have implications for understanding the patterns of autoantibody production in lupus. Anti-DNA antibodies are produced transiently, mainly during periods of disease activity, whereas anti-nRNP/Sm antibody levels are relatively insensitive to disease activity. This may reflect the differential IL-6 dependence of the two responses.
B
ALB/c, SJL/J, and C57BL/6 mice injected intraperitoneally with pristane develop lupus-specific autoantibodies, including anti-nRNP/Sm and ribosomal P, as well as the less disease-specific autoantibodies anti-Su, histone, and single-stranded (ss)DNA (1) (2) (3) . They also develop severe immune complex-mediated glomerulonephritis starting 4-6 mo after pristane treatment (2, 3) . Anti-doublestranded (ds)DNA antibodies, which are implicated in the pathogenesis of lupus nephritis (4, 5) , have so far not been observed, raising questions about the role of anti-dsDNA antibodies in the development of nephritis in these mice. IL-6 production by an expanded macrophage compartment is thought to be instrumental in the pathogenesis of anti-DNA antibodies and nephritis in (NZB/W)F1 mice (6, 7) . In light of these findings and the fact that large amounts of IL-6 are produced upon uptake of pristane by murine peritoneal macrophages (8, 9) , we investigated the role of this cytokine in autoantibody production in pristane-induced lupus. Our data indicate that production of IgG anti-ssDNA, antichromatin and anti-dsDNA antibodies in pristane-treated mice requires IL-6, suggesting that anti-DNA antibody production in lupus is a marker of IL-6 overproduction. Unexpectedly, the frequencies of anti-nRNP/Sm and Su autoantibodies were similar in IL-6 deficient versus intact mice, suggesting that pristane induces autoantibody production by both IL-6-independent and -dependent pathways.
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Materials and Methods
Mice. Mice were generated by five backcrosses of B6/129SV IL-6 ϪրϪ with BALB/cAn. Mice heterozygous for the IL-6 mutation were intercrossed to create IL-6 ϪրϪ and IL-6 ϩրϩ mice and were genotyped by Southern blotting (10) . Female BALB/cAn IL-6 ϪրϪ ( n ϭ 28) and IL-6 ϩրϩ ( n ϭ 26) mice, age 10-12 wk, were injected once intraperitoneally with 0.5 ml of pristane (2,6,10,14-tetramethylpentadecane; Sigma Chemical Co., St. Louis, MO) (1). Control mice (IL-6 ϪրϪ , n ϭ 10 and IL-6 ϩրϩ , n ϭ 10) received 0.5 ml of PBS intraperitoneally. Sera were collected from the tail vein before treatment, at 3 wk, and at 3, 5, and 8 mo after treatment. Mice were housed under specific pathogen-free conditions.
Immunoprecipitation. Analysis of autoantibody specificities by immunoprecipitation was carried out as described previously (1) .
ELISAs. Antigen capture ELISAs for anti-nRNP/Sm and anti-Su antibodies were performed as described, using mouse sera at a dilution of 1:500 and goat anti-mouse IgG second antibodies ( ␥ chain-specific, from Southern Biotechnology Associates, Birmingham, AL) (11, 12) . Anti-ssDNA ELISA was performed as previously described (13) , and data were analyzed using the Mann Whitney test.
Anti-dsDNA antibody ELISA was carried out as previously described with minor modifications (14) . In brief, calf thymus DNA (Sigma Chemical Co.) was extracted with phenol/chloroform/isoamyl alcohol and digested with S1 nuclease (GIBCO BRL, Gaithersburg, MD). Dynex polystyrene microtiter plates (Dynastar, Dynatech, Chantilly, VA) were coated with 100 l/ well of 5 g/ml DNA in SSC, pH 8.0, and incubated at 37 Њ C for 12 h. Sera were tested at a 1:160 dilution followed by alkaline phosphatase-conjugated goat anti-mouse IgG antibodies. Substrate was added, and A 405 nm was determined. Absorbances from blank wells (no serum added) were subtracted.
IgG antichromatin antibodies were measured as previously described (15) . In brief, polyvinyl chloride microtiter plates were coated with 10 g/ml chicken erythrocyte chromatin in boratebuffered saline. Sera were tested at a 1:500 dilution, followed by biotinylated goat anti-mouse IgG (pFc Ј -specific, 1:4,000 dilution, from Dr. P.L. Cohen, University of North Carolina, Division of Rheumatology and Immunology), avidin-conjugated alkaline phosphatase (Zymed Labs, South San Francisco, CA), and p -nitrophenyl phosphate substrate. The A 405 nm of a 1:1,000 dilution of a high titer MRL/ lpr reference serum was assigned a value of 2,048 units, and a 2 11 -fold dilution of this standard a value of 2 units (15) . IgG antichromatin activity in units for each sample was determined as in reference 12.
Fluorescence Assay for Anti-dsDNA Antibodies. Anti-dsDNA antibodies were measured by the Crithidia luciliae kinetoplast staining assay (16) 
Results and Discussion
IL-6 has been implicated in both anti-DNA antibody production and the pathogenesis of nephritis in (NZB/ W)F1 mice (6, 7) , and in the development of autoantibodies in patients with cardiac myxomas (17, 18) . It also is essential for the growth of plasmacytomas in pristane-treated mice (8, (19) (20) (21) . This study was undertaken to evaluate the role of this cytokine in the induction of autoantibodies by pristane in BALB/c mice.
Anti-DNA Antibody Production in Pristane-induced Lupus. The production of IgM anti-ssDNA antibodies 2-3 wk after treating BALB/c mice with pristane (2) appears to be thymusindependent (reference 2 and Richards, H.B., M. Satoh, J.C. Jennette, T. Okano, Y.S. Kanwar, and W.H. Reeves, manuscript submitted for publication). Because IL-6 can stimulate T cell-independent Ig production (22, 23) , the induction of IgM anti-ssDNA antibodies by pristane in BALB/cAn IL-6 ϪրϪ and IL-6 ϩրϩ mice was investigated.
As shown in Fig. 1 , IgM anti-ssDNA antibody levels were similar in IL-6 ϪրϪ versus IL-6 ϩրϩ mice 3 wk after pristane treatment. In contrast, IgG anti-ssDNA antibodies were detected at a high frequency 8 mo after pristane treatment only in IL-6 ϩրϩ mice ( P Ͻ 0.05 versus IL-6 ϪրϪ by Mann Whitney test).
Anti-dsDNA antibodies are highly specific for lupus and are implicated in the pathogenesis of lupus nephritis. However, they were not detected previously in the 6-mo sera from pristane-treated BALB/c mice, a time when severe renal lesions already were apparent (2). In contrast, sera from 10 out of 26 BALB/cAn (IL-6 ϩրϩ ) mice (38%) 8 mo after pristane treatment were strongly positive for antidsDNA antibodies by Crithidia luciliae kinetoplast staining (Table 1 ) at titers ranging from 1:80 to 1:640 (Table 2) . Anti-dsDNA antibodies were not detected in pristanetreated IL-6 ϪրϪ mice or PBS-treated IL-6 ϩրϩ or IL-6 ϪրϪ mice (Table 1) . Although the Crithidia luciliae kinetoplast staining assay is highly specific for anti-dsDNA activity, occasionally antihistone antibodies give a false positive reaction. To exclude that possibility, the sera were tested for IgG anti-dsDNA antibodies by ELISA. The ELISA was somewhat less sensitive than the fluorescence assay, since only sera with titers Ͼ 1:640 gave a significantly stronger reaction by ELISA than the Crithidia -negative group. An anti-ssDNA mAb (6/O2 576-2; from Dr. D. Pisetsky, Duke University, Durham, NC) also showed weak ELISA reactivity. Remarkably, none of the sera from pristanetreated IL-6 ϪրϪ mice bound to S1 nuclease-treated DNA at 8 mo (Fig. 1) .
Together, these results indicate that pristane-treated BALB/cAn mice develop high levels of IgG anti-ssDNA and anti-dsDNA antibodies, and that these autoantibodies are IL-6 dependent. However, the appearance of these autoantibodies is delayed until 8 mo after treatment, which is after the onset of renal disease. Some of the pristane-treated BALB/cAn mice developed IgG anti-dsDNA antibodies at levels comparable to those in MRL/ lpr mice ( Table 2 , Fig.  1 ). Although it has been suggested that anti-dsDNA antibody production can result from polyclonal B cell activation (24) , the marked polyclonal hypergammaglobulinemia seen in both IL-6 ϩրϩ and IL-6 ϪրϪ mice 3-5 mo after pristane treatment was not accompanied by an anti-dsDNA response, suggesting that other mechanisms may be more important in generating these autoantibodies. These may include effects of IL-6 on terminal B cell differentiation (17, 25) .
IgG Antichromatin Antibodies. Like anti-dsDNA, antichromatin antibodies are found at high levels in MRL/ lpr and other lupus mice (15, 26) . Anti-DNA responses are linked to the immune response to chromatin, since T cells specific for histones can help B cells producing anti-DNA antibodies (27) . Thus, it was of interest to see if antichromatin and anti-DNA antibodies exhibit similar IL-6 dependence. Pristane induced high levels of IgG antichromatin antibodies within 3-5 mo, but only in BALB/cAn IL-6 ϩրϩ mice (Figs. 2 and 3, C and D ). Interestingly there was low level spontaneous production of these autoantibodies in aged IL-6 ϩրϩ PBS-treated mice (Fig. 2) , which was absent in IL-6 ϪրϪ animals. Thus, IL-6 may be important for the production of pristane-induced, as well as spontaneous, IgG antichromatin autoantibodies.
Since IL-6 plays an important role in the differentiation of antigen plus CD40 coactivated B cells into antibodysecreting cells (28) , the lack of IgG anti-DNA/chromatin autoantibodies in IL-6-deficient mice may reflect an absolute requirement for IL-6 in the differentiation of germinal center B cells into anti-DNA/chromatin secreting plasma cells. This interpretation is consistent with previous observations that IL-6 is crucial for the development of anti-DNA/chromatin antibodies in spontaneous murine lupus models (6, 7) and that the production of these autoantibodies also is dependent on CD40-CD40 ligand interactions (29, 30) . Rheumatoid factor is not produced in CD40 ligand-deficient MRL/ lpr mice either, whereas antinRNP/Sm antibodies are (30) , suggesting that the latter may be regulated differently than anti-DNA and rheumatoid factor. Like anti-dsDNA, rheumatoid factor was induced by pristane in IL-6 ϩրϩ but not IL-6 ϪրϪ mice (data not shown), suggesting that similar regulatory mechanisms may exist in pristane-induced lupus.
IgG Anti-nRNP/Sm and Anti-Su Antibodies. The IL-6 dependence of IgG anti-DNA and chromatin autoantibodies is consistent with previous observations in the (NZB/ (Fig. 3) . Anti-dsDNA antibodies were detected in the sera by Crithidia luciliae kinetoplast staining at a dilution of 1:20. Table 1 ), the frequencies of anti-nRNP/Sm autoantibodies were comparable in the IL-6 ϪրϪ and IL-6 ϩրϩ mice (Fig. 3 A, Table 1 ), although levels were lower in the IL-6 ϪրϪ mice (Fig. 3 B) . Similarly, the frequencies of antiSu autoantibodies in IL-6 ϩրϩ versus IL-6 ϪրϪ mice were comparable (Table 1 ). In agreement with the ELISA data, both anti-nRNP/Sm and anti-Su autoantibodies were detectable in the sera of IL-6 ϪրϪ by immunoprecipitation of 35 S-labeled cell extracts. We conclude that the induction of anti-nRNP/Sm and Su autoantibodies is IL-6 independent, whereas their levels are influenced by IL-6. Since IgG2a was the predominant isotype of the anti-nRNP/Sm and Su, as well as anti-dsDNA and -chromatin autoantibodies (not shown), it is unlikely that the differential effects of IL-6 on their induction reflects merely an altered ability to produce antibodies of a particular isotype or isotypes. Furthermore, analysis of total Ig levels revealed marked increases in IgG2a, IgG2b, and IgG3 from 1 to 3 mo after pristane treatment both in IL-6 ϩրϩ and IL-6 ϪրϪ mice (data not shown). This was only slightly less dramatic in the IL-6 ϪրϪ group than in the IL-6 ϩրϩ mice.
Although DNA binding is critical for the activation of a subset of anti-Sm B cells (31) , our data argue that the induction of anti-DNA and anti-Sm responses may be at least partially independent processes. This also appears true in CD40 ligand-deficient mice (30) . Whereas anti-DNA/chromatin is CD40 and IL-6 dependent, anti-nRNP/Sm antibody production may be enhanced via a T cell-dependent and CD40-and IL-6-independent mechanism (Richards, H.B., M. Satoh, J.C. Jennette, T. Okano, Y.S. Kanwar, and W.H. Reeves, et al., manuscript submitted for publication). Certain CD40 ligand-negative T cell clones retain the capacity to induce plasma cell differentiation (32) . Recently, it was shown that the CD27-CD70 signaling pathway may promote B cell differentiation into IgG-secreting plasma cells, whereas CD40 ligand-CD40 signaling may be more important for maintaining B cell proliferation and differentiation into memory cells (33, 34) . The role of this or other pathways of CD40 ligandindependent B cell activation in the generation of antinRNP/Sm and Su antibodies remains to be determined.
IL-6 is thought to influence the development of spontaneous human and murine lupus. It may play a role in the induction of autoantibodies (17) and nephritis (35, 36) , as well as in polyclonal B cell activation (37, 38) . Polyclonal hypergammaglobulinemia in lupus may reflect both the overexpression of IL-6 receptors on B cells (37, 39) and, in MRL/lpr mice, increasing IL-6 gene expression and serum levels with age (40) . Although increased IL-6 production in MRL mice is related to the presence of the lpr gene, it is not produced by the abnormal double negative T cells (40) , and may be derived from the expanded macrophage subset of these mice (6, 41) .
Summary and Clinical Implications. The goal of this study was to examine the production of anti-dsDNA antibodies, long considered to be a marker of lupus nephritis (4, 5) , in pristane-induced lupus. Anti-dsDNA antibodies were produced late in the course of pristane-induced lupus and were strictly IL-6 dependent, possibly reflecting the IL-6 overproduction characteristic of pristane-treated mice (8, 9) . However, their onset at 8-11 mo after pristane treatment was well after the establishment of renal disease (2) , arguing that the renal lesions may not be caused directly by antidsDNA antibodies. Nevertheless, renal disease in pristanetreated B6 IL-6 ϪրϪ mice is milder than in IL-6 ϩրϩ controls (Richards, H.B., M. Satoh, M. Shaw, C. Libert, V. Poli, and W.H. Reeves, unpublished data), consistent with the idea that IL-6 itself may contribute to the development of nephritis (42) . Interestingly, although the levels of antinRNP/Sm antibodies also were influenced by IL-6, their frequency was not, suggesting that they may be regulated differently from anti-DNA antibodies.
The different cytokine requirements for anti-dsDNA and anti-Sm antibody production may help to explain differences in the patterns of their expression seen clinically. For example, low levels of antichromatin antibodies developed spontaneously in aged BALB/cAn ϩրϩ mice but not in IL-6 ϪրϪ mice (Fig. 2) , an observation that may be relevant to the increased frequency of antinuclear antibodies (43) and higher IL-6 production (44) in elderly people.
The extreme variability characteristic of anti-dsDNA antibody levels (5) contrasts with the fact that the levels of anti-Sm generally remain relatively stable over time. We speculate that, as in pristane-induced lupus, anti-dsDNA antibody production in human SLE may be IL-6 depen- dent. Thus, anti-dsDNA/chromatin antibody levels might be a surrogate marker for increased IL-6 production, which is associated with active SLE (37) . The induction of anti-DNA antibodies in mice by lipopolysaccharide (45) , a potent inducer of IL-6 (46), raises the possibility that microbial stimulation could trigger both IL-6 production and anti-DNA autoantibody production. Indeed, pristaneinduced lupus is milder in specific pathogen-free than in conventionally housed mice (12) . In view of the importance of anti-DNA antibodies and IL-6 in lupus nephritis, it may be of interest to examine the role of microbial stimulation of IL-6 production in the pathogenesis of lupus flares.
